Round voting button logo

SB465

Classifying xylazine as a schedule III controlled drug.

Chamber Passed·3/16/26

Classifies xylazine as a schedule III controlled drug in New Hampshire.

The bill amends the New Hampshire Controlled Drug Act to classify xylazine as a schedule III controlled drug. This change takes effect on January 1, 2027. The bill allows licensed veterinarians to continue using xylazine for nonhuman species under specific conditions.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the Senate · Mar 16
Current
The House
Next
House floor vote

Sponsors

0
10
RRRRRRRRRR
Democratic CaucusRepublican Caucus

Calendar

Apr 14

1:00 PM

Environment and Agriculture Executive Session

Apr 7

1:00 PM

Environment and Agriculture Work Session

History

Apr 23

House

Inexpedient to Legislate: Motion Adopted Voice Vote 04/23/2026 House Journal 11

Apr 15

House

Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; Regular Calendar)

Apr 15

House

Minority Committee Report: Ought to Pass